Metabolic syndrome in patients with psoriatic disease.
Metabolic syndrome in patients with psoriatic disease.
复制标题
DOI:
10.3899/jrheum.120237
复制
发表时间:
2012-07
影响因子:
--
通讯作者:
Yeung H
中科院分区:
文献类型:
--
作者:
Gelfand JM;Yeung H
Psoriasis is a common Th-1 and Th-17-mediated chronic inflammatory disease that has been associated with metabolic syndrome, a constellation of cardiovascular risk factors including obesity, hypertension, dyslipidemia, and insulin resistance, has been implicated. Overlapping inflammatory pathways and genetic susceptibility may be potential biologic links underlying this association. Multiple epidemiologic studies have consistently demonstrated higher prevalence of metabolic syndrome in patients with psoriasis. Dose-response relationships between more severe psoriasis and higher prevalence of metabolic syndrome components were recently established. This association has important clinical implications for the comprehensive management of psoriasis: Patients with psoriasis should be routinely screened for metabolic syndrome and treated accordingly to manage cardio-metabolic risk, while clinicians should monitor potential effects on treatment efficacy and safety in patients with co-morbid psoriasis and metabolic syndrome. Further research will be necessary to establish the directionality of this association and to explore the impact of treatment on these co-morbid diseases.
登录
查看更多内容
影响因子:
120.7
作者:
Gelfand, Joel M.;Neimann, Andrea L.;Troxel, Andrea B.
通讯作者:
Troxel, Andrea B.
影响因子:
13.8
作者:
Gelfand, JM;Feldman, SR;Margolis, DJ
通讯作者:
Margolis, DJ
DOI:
10.1111/j.1468-3083.2008.02936.x
发表时间:
2009-01-01
影响因子:
9.2
作者:
Balci, D. D.;Balci, A.;Egilmez, E.
通讯作者:
Egilmez, E.
DOI:
10.1111/j.1365-2133.2010.09941.x
发表时间:
2010-09
期刊:
The British journal of dermatology
影响因子:
--
作者:
Abuabara K;Azfar RS;Shin DB;Neimann AL;Troxel AB;Gelfand JM
通讯作者:
Gelfand JM
影响因子:
11.1
作者:
Ahlehoff, O.;Gislason, G. H.;Hansen, P. R.
通讯作者:
Hansen, P. R.